First Capital Advisors Group’s ResMed RMD Stock Holding History

First Capital Advisors Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9.18K	Buy	+42	New	+$9.36K	﹤0.01%	565
2018 Q2	–	Sell	-10	Closed	-$1K	–	638
2018 Q1	$1K	Buy	+10	New	+$945	﹤0.01%	829

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Capital Advisors Group's RMD Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in ResMed (RMD) in Q2 2023: 42 shares worth $9.18K. The stake represents ﹤0.01% of the portfolio and ranks #565 among its holdings. This is a return to the name: First Capital Advisors Group previously reported a position in RMD as recently as Q1 2018.

First Capital Advisors Group first reported a position in RMD in Q1 2018 and has held it in 2 quarters since. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

First Capital Advisors Group held 42 shares of ResMed worth $9.18K as of Q2 2023.
ResMed was a new First Capital Advisors Group position in Q2 2023.
ResMed made up ﹤0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #565 holding.
First Capital Advisors Group first reported a position in ResMed in Q1 2018 and has held it in 2 quarters since.
731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.